Invesco Ltd stated that they own 4.1% of Chemed Co. (NYSE:CHE) in a Schedule 13G/A disclosure that was filed with the Securities and Exchange Commission (SEC) on Friday, January 29th. The investor owns 693,099 shares of the stock valued at $94,261,464. The filing is available through the SEC website at this link.

Several other large investors also recently modified their holdings of the company. Strs Ohio raised its stake in shares of Chemed by 33.3% in the fourth quarter. Strs Ohio now owns 2,000 shares of the company’s stock worth $299,000 after buying an additional 500 shares during the last quarter. Meeder Asset Management raised its stake in shares of Chemed by 25.4% in the fourth quarter. Meeder Asset Management now owns 7,259 shares of the company’s stock worth $1,087,000 after buying an additional 1,470 shares during the last quarter. Louisiana State Employees Retirement System bought a new stake in shares of Chemed during the fourth quarter worth approximately $1,124,000. State Board of Administration of Florida Retirement System raised its stake in shares of Chemed by 0.8% in the fourth quarter. State Board of Administration of Florida Retirement System now owns 9,698 shares of the company’s stock worth $1,453,000 after buying an additional 74 shares during the last quarter. Finally, California State Teachers Retirement System raised its stake in shares of Chemed by 1.3% in the fourth quarter. California State Teachers Retirement System now owns 31,601 shares of the company’s stock worth $4,734,000 after buying an additional 412 shares during the last quarter.

Shares of Chemed Co. (NYSE:CHE) traded up 2.57% during midday trading on Friday, reaching $139.50. 46,457 shares of the company’s stock traded hands. The firm has a market cap of $2.35 billion and a PE ratio of 22.08. Chemed Co. has a 52-week low of $100.50 and a 52-week high of $160.12. The company has a 50 day moving average of $145.87 and a 200 day moving average of $144.18.

A number of equities research analysts recently commented on the stock. RBC Capital raised their price objective on shares of Chemed from $129.00 to $154.00 and gave the stock a “sector perform” rating in a report on Monday, October 26th. Zacks Investment Research lowered shares of Chemed from a “buy” rating to a “hold” rating in a research note on Thursday, December 24th. Finally, Oppenheimer reiterated an “outperform” rating and issued a $152.00 price target (up from $150.00) on shares of Chemed in a research note on Monday, October 26th.

In other news, CEO Kevin J. Mcnamara sold 6,000 shares of the stock in a transaction that occurred on Friday, November 6th. The shares were sold at an average price of $157.02, for a total transaction of $942,120.00. Following the completion of the transaction, the chief executive officer now directly owns 167,736 shares of the company’s stock, valued at approximately $26,337,906.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Spencer S. Lee sold 5,000 shares of the stock in a transaction that occurred on Tuesday, November 24th. The shares were sold at an average price of $154.10, for a total transaction of $770,500.00. Following the transaction, the executive vice president now directly owns 43,405 shares of the company’s stock, valued at $6,688,710.50. The disclosure for this sale can be found here.

Chemed Corporation (NYSE:CHE) purchases, operates and divests subsidiaries engaged in diverse business activities. The Company operates its business in two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS and Innovative Hospice Care are trademarks and service marks of VITAS Healthcare Corporation, a wholly owned indirect subsidiary of the Company. The Company’s Roto-Rooter segment provides plumbing and drain cleaning services to both residential and commercial customers. The Roto-Rootera trademarks and service marks are used and advertised by Roto-Rooter Corporation, a wholly owned indirect subsidiary of the Company. The Company operates through two wholly owned subsidiaries: VITAS Healthcare Corporation and Roto-Rooter Group, Inc.

12 Month Chart for NYSE:CHE

Receive News & Ratings for Chemed Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Co. and related companies with MarketBeat.com's FREE daily email newsletter.